Rajamannar Thennati
Vadodara, GJ, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Binding Kinetics, Bias, Receptor Internalization and Effects on Insulin Secretion in vitro and in vivo of a Novel GLP-1R/GIPR Dual Agonist, HISHS-2001.
Journal: bioRxiv : the preprint server for biology
Published: January 27, 2025
Binding kinetics, bias, receptor internalization and effects on insulin secretion in vitro and in vivo of a novel GLP-1R/GIPR dual agonist, HISHS-2001.
Journal: Diabetes, obesity & metabolism
Published: January 17, 2025
Mitochondria-targeted esculetin and metformin delay endothelial senescence by promoting fatty acid β-oxidation: Relevance in age-associated atherosclerosis.
Journal: Mechanisms of ageing and development
Published: January 05, 2024
Correction to: Therapeutic efficacies of mitochondria‑targeted esculetin and metformin in the improvement of age‑associated atherosclerosis via regulating AMPK activation.
Journal: GeroScience
Published: December 25, 2023
Mitochondria targeted esculetin administration improves insulin resistance and hyperglycemia-induced atherosclerosis in db/db mice.
Journal: Journal of molecular medicine (Berlin, Germany)
Published: November 14, 2023
Therapeutic efficacy of mitochondria-targeted esculetin in the improvement of NAFLD-NASH via modulating AMPK-SIRT1 axis.
Journal: International immunopharmacology
Published: August 01, 2023
Therapeutic efficacies of mitochondria-targeted esculetin and metformin in the improvement of age-associated atherosclerosis via regulating AMPK activation.
Journal: GeroScience
Published: June 23, 2023
Mitochondria-targeted esculetin mitigates atherosclerosis in the setting of aging via the modulation of SIRT1-mediated vascular cell senescence and mitochondrial function in Apoe-/- mice.
Journal: Atherosclerosis
Published: April 19, 2022
A functional and self-assembling octyl-phosphonium-tagged esculetin as an effective siRNA delivery agent.
Journal: Chemical communications (Cambridge, England)
Published: November 05, 2021
In vivo and in vitro characterization of GL0034, a novel long-acting glucagon-like peptide-1 receptor agonist.
Journal: Diabetes, obesity & metabolism
Published: August 19, 2021
Analytical characterization of recombinant hCG and comparative studies with reference product.
Journal: Biologics : targets & therapy
Published: February 13, 2018
Lipodox® (generic doxorubicin hydrochloride liposome injection): in vivo efficacy and bioequivalence versus Caelyx® (doxorubicin hydrochloride liposome injection) in human mammary carcinoma (MX-1) xenograft and syngeneic fibrosarcoma (WEHI 164) mouse models.
Journal: BMC cancer
Published: December 15, 2016
Last Updated: 09/26/2026